Exploring the Role of MAPSE as a Bedside Indicator for Ventriculoarterial Coupling in Critical Care Settings
-
By
-
Jinyang Yu
-
October 5, 2026
Clinical Scorecard: Exploring the Role of MAPSE as a Bedside Indicator for Ventriculoarterial Coupling in Critical Care Settings
At a Glance
| Category | Detail |
| Condition | Ventriculoarterial Coupling |
| Key Mechanisms | Mechanical energy efficiency of the left ventricle |
| Target Population | Critically ill patients |
| Care Setting | Critical care settings |
Key Highlights
- VA coupling responses are unpredictable and correlate weakly with cardiac output changes.
- MAPSE may serve as a bedside surrogate for VA coupling.
- MAPSE has strong prognostic value among critically ill patients.
- Current monitoring strategies for VA coupling are time-consuming and complex.
- Correlation between MAPSE and non-invasive VA coupling estimates requires further validation.
Guideline-Based Recommendations
Diagnosis
- MAPSE is acknowledged in several critical care guidelines.
Management
- Monitoring and optimizing VA coupling is important for hemodynamic optimization.
Monitoring & Follow-up
- Effective monitoring strategies for VA coupling are currently lacking.
Risks
- Poor VA coupling may increase the risk of cardiac decompensation.
Patient & Prescribing Data
Critically ill patients requiring hemodynamic monitoring.
MAPSE may provide insights into therapeutic effects and VA coupling optimization.
Clinical Best Practices
- Utilize MAPSE as a potential bedside surrogate for VA coupling.
- Consider serial monitoring of VA coupling for hemodynamic optimization.
Related Resources & Content